Plimoth Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-419
Closed -$243K 178
2025
Q4
$243K Sell
419
-5
-1% -$2.83K 0.05% 165
2025
Q3
$206K Sell
424
-166
-28% -$77.3K 0.05% 167
2025
Q2
$239K Hold
590
0.06% 160
2025
Q1
$294K Sell
590
-243
-29% -$132K 0.08% 149
2024
Q4
$433K Sell
833
-2
-0.2% -$1.1K 0.11% 127
2024
Q3
$517K Buy
835
+13
+2% +$7.7K 0.13% 122
2024
Q2
$455K Hold
822
0.12% 122
2024
Q1
$478K Buy
822
+13
+2% +$7.29K 0.13% 122
2023
Q4
$429K Sell
809
-20
-2% -$9.68K 0.12% 127
2023
Q3
$420K Buy
829
+148
+22% +$78.9K 0.13% 124
2023
Q2
$355K Sell
681
-35
-5% -$18.9K 0.11% 135
2023
Q1
$413K Sell
716
-8
-1% -$4.51K 0.13% 128
2022
Q4
$398K Buy
724
+20
+3% +$10.6K 0.13% 132
2022
Q3
$357K Buy
704
+5
+0.7% +$2.8K 0.12% 133
2022
Q2
$380K Sell
699
-1,365
-66% -$751K 0.12% 133
2022
Q1
$1.22M Sell
2,064
-294
-12% -$169K 0.32% 88
2021
Q4
$1.57M Sell
2,358
-96
-4% -$59.9K 0.4% 76
2021
Q3
$1.4M Buy
2,454
+24
+1% +$13.2K 0.4% 76
2021
Q2
$1.23M Buy
2,430
+451
+23% +$213K 0.34% 83
2021
Q1
$903K Buy
1,979
+504
+34% +$241K 0.27% 99
2020
Q4
$687K Buy
+1,475
New +$692K 0.21% 110

Other funds holding TMO

Plimoth Trust's TMO Position: Q1 2026 in Review

Plimoth Trust sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 419 shares — an estimated $243K sold.

Plimoth Trust first reported a position in TMO in Q4 2020 and held it in 21 quarters. The position peaked at $1.57M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Plimoth Trust reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Plimoth Trust sold 419 Thermo Fisher Scientific shares in Q1 2026, an estimated $243K.
  • Plimoth Trust first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 21 quarters.
  • Plimoth Trust's Thermo Fisher Scientific position peaked at $1.57M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.